Vanguard Rapid Resp

Vanguard Rapid Resp intranasal vaccine line provides dogs a one-year duration of immunity (DOI) claim for the Bordetella bronchiseptica (Bb), canine adenovirus type 2 (CAV-2) and canine parainfluenza virus (CPiV) fractions. Vanguard Rapid Resp is the first and only intranasal vaccine line in the United States that has been demonstrated to provide one year of protection against three important canine infectious respiratory diseases. Additionally, the line is the broadest among 0.5 ml-intranasal vaccines used in dogs in the United States, according to Zoetis. Vanguard Rapid Resp is available in three antigenic combinations (Bb + CPiV + CAV-2; Bb + CPiV; Bb only), and all of these choices can be administered with a syringe or a syringe-free applicator.

100 Campus Drive Florham Park, NJ 07932
Tel: 1-888-963-8471